2seventy bio, Inc. (TSVT) Reports In-Line Q3 EPS

2seventy bio, Inc. (NASDAQ: TSVT) reported Q3 EPS of ($0.19), in-line with the analyst estimate of ($0.19). Revenue for the quarter came in at $13.53 million versus the consensus estimate of $16.18 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
• Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral